Table II.
Demographic data of 12 absence epilepsy patients
Patient no. | Sex | Age | Age at seizure onset | Seizure type frequency | Antiepileptic drugs | Frequency of SWD (Hz) |
---|---|---|---|---|---|---|
1 | M | 7 | 4 | Abs 20/day | VPA | 2.5–3.5 |
2 | M | 24 | 10 | Abs several/day | VPA | 3 |
3 | F | 16 | 3 | Abs 10/day | None | 3–3.5 |
4 | M | 17 | 4 | Abs daily, GTCS 2/year | None | 3–3.5 |
5 | M | 21 | 13 | Abs several/day | VPA | 2–4 |
6 | M | 5 | 4 | Abs 40/day | None | 3 |
7 | M | 18 | 9 | Abs 2–3/week, GTCS 1/month | None | 2.5–3 |
8 | M | 8 | 7 | Abs several/day | VPA CZP LTG | 3–4 |
9 | M | 14 | 9 | Abs 7–8/day | None | 3 |
10 | M | 18 | 5 | Abs 2–3/day | None | 3–4 |
11 | F | 9 | 7 | Abs several/day | None | 3–4 |
12 | F | 7 | 6 | Abs several/day | None | 3–3.5 |
Abs, absence seizure; GTCS, generalized tonic clonic seizure; VPA, valproic acid; LTG, lamotrigine; CZP, clonazepam.